 NEW YORK, May 17, 2021 PRNewswire -- Petros Pharmaceuticals, Inc. Petros or the Company Nasdaq: PTPI, a leading provider of therapeutics for mens health, today announced financial results for the first quarter ended March 31, 2021. First Quarter Highlights: 300 increase in STENDRA net sales during the first quarter of 2021 vs. 